Levalbuterol versuss levalbuterol plus ipratropium in the treatment of severe acute asthma.

BACKGROUND The National Asthma Education and Prevention Program (NAEPP) Expert Panel Report 3 guidelines advise the addition of ipratropium bromide to short-acting β-agonist therapy for the treatment of patients with severe acute asthma exacerbation. METHODS This was a prospective, double-blind, randomized, controlled study involving 141 adults… CONTINUE READING